Table 1 Characteristics of 49 hepatoid adenocarcinoma of the stomach patients
Characteristic | No. of patients (%) |
|---|---|
Sex | |
Male | 43(87.8%) |
Female | 6(12.2%) |
BMI | |
< 18.5 | 4(8.2%) |
18.5–24 | 20(40.8%) |
> 24 | 25(51.0%) |
Primary site of the tumor | |
Gastroesophageal junction | 17(34.7%) |
Body of stomach | 9(18.4%) |
Antrum of stomach | 23(46.9%) |
Borrmann type | |
I | 1(2.0%) |
III | 47(96.0%) |
IV | 1(2.0%) |
The serum level of AFP | |
≤ 450 ng/ml | 39(79.6%) |
> 450 ng/ml | 10(20.4%) |
The serum level of CEA | |
≤ 5.0 ng/ml | 26(53.1%) |
> 5.0 ng/ml | 23(46.9%) |
The serum level of CA199 | |
≤ 51.51 ng/ml | 44(89.8%) |
> 51.51 ng/ml | 5(10.2%) |
The serum level of CA724 | |
≤ 5.0 ng/ml | 36(73.5%) |
> 5.0 ng/ml | 13(26.5%) |
The serum level of CA125 | |
≤ 50.0 ng/ml | 48(98.0%) |
> 50.0 ng/ml | 1(2.0%) |
Histopathology | |
Well differentiated adenocarcinoma | 10(20.4%) |
Moderately differentiated adenocarcinoma | 5(10.2%) |
Poorly differentiated adenocarcinoma | 34(69.4%) |
Lauren's classification | |
Intestinal type | 31(63.3%) |
Diffuse type | 3(6.1%) |
Mixed type | 15(30.6%) |
T classicationa | |
T1 | 3(6.1%) |
T2 | 9(18.4%) |
T3 | 27(55.1%) |
T4 | 10(20.4%) |
N classicationa | |
N0 | 3(6.1%) |
N1 | 5(10.2%) |
N2 | 26(53.1%) |
N3 | 15(30.6%) |
Clinical stagea | |
IA | 2(4.0%) |
IB | 1(2.0%) |
IIA | 8(16.0%) |
IIB | 9(2.0%) |
IIIA | 17(18.4%) |
IIIB | 7(14.3%) |
IIIC | 2(4.1%) |
IV | 3(6.1%) |
Pathological vascular tumor thrombus | 30(61.2%) |
CT finding of vascular tumor thrombus | 0(NA) |
Neoadjuvant chemotherapy regimens | |
Yes | 19(38.8%) |
No | 30(61.2%) |